This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Evec Incorporated, Okayama University. Active years: 2013-2017.
Company Filing History:
2 out of 4 
1 out of 138 
Years Active: 2013-2017
Title: Takashi Torashima: Innovator in Antibody Development
Introduction
Takashi Torashima is a prominent inventor based in Hokkaido, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of 2 patents, his work focuses on innovative solutions for treating inflammatory diseases and viral infections.
Latest Patents
One of his latest patents is for a humanized anti-HMGB1 antibody or antigen-binding fragment thereof. This invention provides a humanized anti-HMGB1 antibody that specifically binds to a sequence consisting of the C-terminal 8 amino acid residues (EEEDDDDE) of the HMGB1 protein. It is effective for the treatment or prevention of various inflammatory diseases related to this protein. Additionally, the invention includes a pharmaceutical composition comprising such an antibody or antigen-binding fragment.
Another significant patent involves a monoclonal antibody capable of binding to a specific discontinuous epitope occurring in the AD1 region of human cytomegalovirus GB glycoprotein, along with its antigen-binding fragment. This invention provides a pharmaceutical composition for human cytomegalovirus (HCMV), which is responsible for various disease states. The composition includes a monoclonal antibody and an antigen-binding fragment that specifically binds to the AD1 region of glycoprotein gB, demonstrating excellent neutralizing capacity.
Career Highlights
Throughout his career, Takashi Torashima has worked with notable organizations such as Evec Incorporated and Okayama University. His experience in these institutions has allowed him to advance his research and contribute to the scientific community.
Collaborations
He has collaborated with esteemed colleagues, including Kenzo Takada and Rika Kurino. These partnerships have further enriched his work and expanded the impact of his inventions.
Conclusion
Takashi Torashima is a distinguished inventor whose work in antibody development has the potential to revolutionize treatments for inflammatory diseases and viral infections. His innovative patents reflect his commitment to advancing biotechnology and improving healthcare outcomes.